Trials / Conditions / Intermediate Uveitis

Intermediate Uveitis

10 registered clinical trials studyying Intermediate Uveitis.

Status	Trial	Sponsor	Phase
Withdrawn	Intravitreal Sirolimus as Therapeutic Approach to Uveitis NCT01280669	Stanford University	Phase 2
Unknown	Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infec NCT04126850	Fakultas Kedokteran Universitas Indonesia	—
Completed	Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis NCT02879084	CHU de Quebec-Universite Laval	—
Completed	Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients NCT02764697	Tampa Bay Uveitis Center, LLC	Phase 4
Completed	Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis NCT02746991	EyePoint Pharmaceuticals, Inc.	Phase 3
Unknown	Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The NCT01717170	University of Nebraska	Phase 1 / Phase 2
Completed	Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis NCT01789320	Clearside Biomedical, Inc.	Phase 1 / Phase 2
Completed	Sirolimus as Therapeutic Approach to Uveitis NCT00908466	Johns Hopkins University	Phase 1
Completed	Retisert and Cataract Surgery in Patients With Severe Uveitis NCT00570830	Duke University	N/A
Completed	A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis NCT00333814	Allergan	Phase 2 / Phase 3